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Background: The epidemiology of diabetes and Ramadan fasting was reported from many Muslim countries,
but not from Libya.
Methodology: We interviewed 493 consecutive diabetic patients at Benghazi Diabetes and Endocrine Center
for the potential complications of fasting during Ramadan.
Results: We found 70% of diabetic patients completed the 30 days of Ramadan fasting. Hypo- and
hyperglycemia was the most commonly reported complications especially during the first two weeks of
Ramadan month.
Conclusion: It seems majority of diabetic patients in Libya manage to fast during Ramadan month. Patient
education and early planned adjustment of diabetic medication is needed to decrease the frequency of diabetic
complication during Ramadan month.
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R
amadan fasting for diabetics represents a chal-
lenge to both patient and physician. The study of
epidemiology of diabetes and Ramadan (EPI-
DIAR study) reported that about 43% of type-1 and 79%
of type-2 patients managed to fast a minimum of 15 days
(1). However, although the study included patients from
13 Muslim countries, it did not involve patients from
Libya. In Libya it is estimated that there are about
300,000 diabetics, most of whom are adults who try to
observe fasting eachyear (2, 3). Since culture, educational
level and the standards of care vary widely between
different Muslim countries, we think that fasting and
complication patterns among Libyan diabetics might not
be similar to those in other Muslim countries. Moreover,
only a few small studies have been done in Libya on
diabetes and Ramadan fasting (4, 5).
Aims and objectives
The purpose of this study was to define the frequency of
fasting and incidence of complications among Libyan
diabetic patients during Ramadan.
Subjects and methods
Benghazi is the second largest city in Libya with
population of about 670,797 inhabitants and 14.1%
prevalence rate of diabetes mellitus (DM) (6), with
type-1 constituting about 6% of all cases. We interviewed
and reviewed the records of 493 consecutive diabetic
patients who attended the Benghazi Diabetes and Endo-
crine Center (BDEC) during the first week after Eid Elfitr
1429 Hijri (2008), and a standard form was filled by the
authors. The following parameters were assessed: age,
sex, type of diabetes, duration of diabetes, type and doses
of treatment before and during Ramadan, level of HbA1c
within three months before Ramadan, number of non-
fasted days, causes of breaking the fast, number and time
of self-reported hypo- and hyperglycemic episodes, and
any history of hospital admission during the preceding
Ramadan and the reason for it.
Hypoglycemia was defined as symptoms that were
perceived by the patient as hypoglycemia and urged him/
her to break fast with or without documented low blood
glucose, and it was categorized as severe or mild. A severe
hypoglycemic episode was defined as the episode that
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assistance from another person. Mild hypoglycemia was
defined as a hypoglycemic episode that was treated by the
person with diabetes alone without need for assistance.
Severe hyperglycemia was defined as a self-reported
blood glucose level ]300 mg/dl.
Statistics
Data were expressed as mean9standard deviation (SD)
and differences between groups were tested using the Chi-
squared test and independent-samples t-test.
Differences were considered significant when the
P-value wasB0.05.
Results
Of the 493 patients, 95% were type-2 diabetics, 50.3%
were males and 39% had their HbA1c checked within
three months before Ramadan. Mean age was 59911.7
years, mean duration of diabetes was 11.3910 years, and
mean HbA1c (for those who had HbA1c results) was
7.891.6. About 27% of the patients had no treatment
changes during Ramadan fasting. The mean number of
fasted days was 28.594.6 days. About 70.4% of patients
completed 30 days of fasting and 97.5% fasted at least 15
days (Table 1). The main reason of breaking the fast was
hypoglycemia (43.4% of causes) followed by severe
hyperglycemia (27%), while other causes constituted
about 30% (Fig. 1). About 14.6% experienced mild
hypoglycemia, 3.2% had severe hypoglycemia and 11.2%
had severe hyperglycemia. Only 5.1% were admitted
to hospital during the study period (Table 1). There was
no significant difference between type-1 and type-2
diabetics regarding number of days fasted, frequency of
hypoglycemia or severe hyperglycemia, or admission rate
during Ramadan (Table 2). Among type-2 diabetic
patients during Ramadan fasting, 77.3% were on insulin
therapy, 20.5% were on oral anti-diabetics, and 2.2% were
on diet control alone. There was no significant difference
between those who were treated with insulin or with oral
anti-diabetic agents in the mean HbA1c, mean number of
fasted days, admission rate or incidence of hypoglycemia,
or severe hyperglycemia (Table 3).
The incidence of hypoglycemia during Ramadan was
31 episodes/100 patients, while the incidence of severe
hyperglycemia was 17 episodes/100 patients (Table 4).
About 74% of hypoglycemic episodes and 79% of
hyperglycemic episodes occurred during the first two
weeks of Ramadan (Fig. 2), and about 90% of all hypo-
and hyperglycemic episodes occurred during the day-
time. Females had a significantly higher frequency of
severe hypoglycemic episodes (4.9% vs. 1.6%, p0.04)
and a lower mean number of fasting days than
males (27.895.9 vs. 29.2492.6, p0.001). Patients
Table 1. General characteristics of the study group
Males Females p-value Total
Number of patients 248 245 493
Mean age (years) 60.2912.7 57.9910.5 0.029 59911.7
Mean duration of diabetes (years) 11.497.5 11.297.8 0.7 11.3910
No dose change 27.4% 26.1% 0.74 26.8
Mean number of fasted days 29.2492.6 27.895.9 0.001 28.594.6
Fasted complete month 73.8% 66.9% 0.09 70.4%
]15 days fasting 99.6% 95.6% 0.003 97.5%
Mild hypoglycemia 14.1% 15.1% 0.75 14.6%
Severe hypoglycemia 1.6% 4.9% 0.04 3.2%
Hyperglycemia 12.9% 9.4% 0.21 11.2%
Admission 4.8% 5.3% 0.81 5.1%
Type-2 94.4% 95.9% 0.42 95.1%
Mean HbA1c 7.9%91.7 7.6%91.4 0.26 7.8%91.6
HbA1c checked 3 m 37.9% 40% 0.63 38.9%
9 Refers to standard deviation. HbA1c checked 3 m: Percent of patients who had their HbA1c checked within three months before
Ramadan.
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Fig. 1. Percentage of causes of breakfasting during Rama-
dan.
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Type-1 Type-2 p-value All
Number of patients 24 469 493
Mean age (years)9SD 38.3915 60.1910.5 0.000 59911.7
Mean duration (years)9SD 14.2911.3 11.297.4 0.06 11.3910
No dose change 25% 26.9% 0.84 26.8
Mean fasting (days)9SD 27.596.6 28.594.5 0.29 28.594.6
Full fasting 70.8% 70.4% 0.96 70.4%
]15 days fasting 95.8% 97.7% 0.57 97.5%
Mild hypoglycemia 20.8% 14.3% 0.3 14.6%
Severe hypoglycemia 4.2% 3.2% 0.79 3.2%
Hyperglycemia 20.8% 10.7% 0.12 11.2%
Admission 8.3% 4.9% 0.45 5.1%
Males 58.9% 49.9% 0.42 50.3%
Mean HbA1c9SD 8.2%91.7 7.7%91.6 0.32 7.8%91.6
HbA1c checked 45.8% 38.59% 0.47 38.9%
Table 3. Comparison between type-2 patients according to the type of treatment
Insulin Oral anti-diabetics p-value Diet alone
Number of patients 357 101 11
Mean age (years)9SD 60.5910.1 59.6911.3 0.43 5099.7
Mean duration (years)9SD 12.697.3 6.895.8 0.000 6.193.9
Mean HbA1c (%)9SD 7.8%91.4 7.7%91.8 0.78 7%92.1
HbA1c checked 34.1% 47.5% 0.014 90%
Mean fasted days9SD 28.594.7 28.694.1 0.76 29.990.3
Mild hypoglycemia 14.2% 15.8% 0.69 0
Severe hypoglycemia 3.9% 0.99% 0.14 0
Severe hyperglycemia 10.9% 9.9% 0.76 9%
Admission rate 4.7% 5.9% 0.63 0
Table 4. Incidence of acute glycemic derangement
Total number of
episodes
Incidence
rate
Mild hypoglycemia 132 episodes 26/100 patient/
month
Sever hypoglycemia 24 episodes 4.8/100 patient/
month
Hypoglycemia requiring
admission
1 episode 0.2/100 patient/
month
Any hypoglycemia 156 episodes 31/100 patient/
month
Severe hyperglycemia 84 episodes 17/100 patient/
month
Hyperglycemia requiring
admission
5 episodes 1/100 patient/
month
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Fig. 2. Time trend of hypoglycemia and hyperglycemia
during Ramadan.
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cantly higher baseline HbA1c than other patients (8.49
1.1% vs. 7.691.6%, p0.02). They also had a signifi-
cantly lower mean number of fasting days (26.995.7%
vs. 2994, p0.001).
Discussion
Both type-1 and type-2 diabetic patients in Benghazi
managed to fast more frequently than diabetics in other
Muslim countries, with a remarkably lesser frequency of
hypo- and hyperglycemia (Table 5). It is possible that
Libyan diabetics are more motivated to fast than those in
other Muslim countries. More likely, however, is that
about three-quarters of the Libyan patients had some
treatment adjustment during Ramadan as compared to
less than one-third of those in the EPIDIAR study (1),
which probably contributed to the lower rate of hypo-
and hyperglycemia, and hence to a lower frequency of
breaking the fasting.
The most common complications that occurred during
Ramadan were hypoglycemia followed by hyperglycemia,
and these were the main two reasons for breaking the
fast, as reported elsewhere (1). However, both types of
episodes were remarkably less frequent during the last
two weeks as compared to the first two weeks, perhaps
because patients adjust their dietary habits and schedules
to suit their condition as the days go by.
The definition of hypoglycemia used in this study
depended mainly on patients’ perception of symptoms,
which means that in principle episodes of hypoglycemia
might go unnoticed. However, patients are probably
unlikely to miss feeling a hypoglycemic episode because
it would become exacerbated as the fasting continued
during the day. On the other hand, we might have
included some non-hypoglycemic episodes that were
interpreted as hypoglycemia by the patients. Therefore,
we believe that the reported figure of the frequency of
hypoglycemic episodes might be a slight overestimate
rather than an underestimate of the frequency of these
episodes.
There was no significant difference between type-1 and
type-2 diabetics regarding fasting rate, admission rate and
frequency of hypo- and hyperglycemic episodes during
Ramadan. These results are contrary to the reported
higher risk of complications in type-1 patients during
Ramadan fasting (7). The mean HbA1c in type-1 patients
was 8.291.7%, which is above the currently recom-
mended goal of B7%. If type-1 patients had a strict
glycemic control with mean HbA1c level lower than 7%,
it would be more likely that they will get a more frequent
hypoglycemic episodes. Nevertheless the number of type-
1 diabetics in this study was too few to draw conclusions.
Conclusion
Most type-2 diabetic patients in Libya managed to fast
during Ramadan. Patient education and adjustment of
doses throughout Ramadan is needed to decrease the risk
of both hypo- and hyperglycemia. Further large studies
are needed to study the effects of Ramadan fasting on
type-1 diabetic patients in Libya.
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Table 5. Comparison between BDEC study and EPIDIAR study
BDEC study (Benghazi, Libya) EPIDIAR (13 Muslim country)
Lunar year (Gregorian) 1429 Hijri (2008) 1422 Hijri (2001)
Total number of patients 493 12,243
Number of patients/country 493 7571,357
Percentage of Type-2 DM 95.1% 91.3%
Mean age for type-19SD 38.3915 years 31912.7 years
Mean age for type-29SD 60.1910.5 years 54911.0 years
Mean duration of type-1 DM9SD 14.2911.3 years 1097.6 years
Mean duration of type-2 DM9SD 11.297.4 years 7.695.8 years
Dose changes during Ramadan 73.2% 27.9%
Type-1 fasting ]15 days 95.8% 9.471.6%
Type-2 fasting ]15 days 97.7% 57.889.8%
Mean fasting for type-1 27.5 days 18.125.6 days
Mean fasting for type-2 28.5 days 23.928.5 days
Hypoglycemia requiring admission 0.2% 2.6%
Hyperglycemia requiring admission 1% 4.7%
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